Clinical Trials Browser

Phase 1/2 × INDUSTRY × GSK2110183 × Clear all

NCT01653912 2018-04-02

Dose-finding Study in Platinum-Resistant Ovarian Cancer

Phase 1/2 Completed

59 enrolled 18 charts

Neoplasms